Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02151487 · ClinicalTrials.gov registry record
A Comparison of Ropivacaine Alone Versus Combination of Dexamethasone and Clonidine for Block
A clinical trial of Upper-extremity Surgery, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 97
- Enrollment target
- 1
- Study location
NCT02151487 is a study of Upper-extremity Surgery that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 97 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02151487, a study of Upper-extremity Surgery, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this randomized, observer-blinded study is to evaluate the postoperative analgesic efficacy of adding dexamethasone and clonidine to ropivacaine in supraclavicular nerve block. The investigators hypothesized that addition of dexamethasone and clonidine to ropivacaine would prolong the duration of analgesia in supraclavicular nerve block compared with ropivacaine alone.
Conditions Studied
Interventions
- DRUG Ropivacaine
- DRUG Ropivacaine and dexamethasone
- DRUG Ropivacaine and clonidine
- DRUG Ropivacaine, dexamethasone and clonidine
Study Locations (1)
Texas
- Parkland Health Hospital System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-08-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02151487
The ClinicalTrials.gov registry entry for NCT02151487 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Upper-extremity Surgery appearing as the primary indexed condition, and to 4 interventions - of which Ropivacaine is the first listed.
NCT02151487 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02151487 about?
NCT02151487 is a clinical study titled "A Comparison of Ropivacaine Alone Versus Combination of Dexamethasone and Clonidine for Block". The aim of this randomized, observer-blinded study is to evaluate the postoperative analgesic efficacy of adding dexamethasone and clonidine to ropivacaine in supraclavicular nerve block. The investigators hypothesized that addition of dexamethasone and clonidine to ropivacaine would prolong the dur...
What is the current status of trial NCT02151487?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2014-03. Estimated completion is 2016-08-20.
What conditions does trial NCT02151487 study?
This clinical trial studies the following conditions: Upper-extremity Surgery.
What interventions are being tested in trial NCT02151487?
The interventions under investigation include: Ropivacaine (DRUG), Ropivacaine and dexamethasone (DRUG), Ropivacaine and clonidine (DRUG), Ropivacaine, dexamethasone and clonidine (DRUG).
Who is sponsoring clinical trial NCT02151487?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02151487 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Upper-extremity Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.